Viral dynamics after the initiation of treatment with or without RAL.

<p>(A) Blue and pink lines show the viral load relative to baseline for study participants in the QUAD treatment and RAL-combination therapy, respectively. Black lines represent the median values for each group. In the last phase, between about day 15 and day 30, the viral load in the RAL-combination participants is ~1-log lower (Δ~90% reduction) than the viral load in the quad-therapy group participants. (B) The median viral load profiles for each group present two phases of decay (1a and 2), but in addition the RAL-combination therapy includes an intermediate phase, 1b.